Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Aug 1997, 2047-2050, Vol 35, No. 8
RA Williamson, T Lazzarotto, PP Sanna, RB Bastidas, B Dalla Casa, G Campisi, R Burioni, MP Landini and DR Burton
The determination and quantitation of peripheral blood leukocytes (PBLs)
expressing human cytomegalovirus (HCMV) antigens is widely employed in
clinical virology for rapid diagnosis of HCMV-related infections. We
describe how CMV antigenemia may be accurately detected by means of human
recombinant monoclonal Fab fragments rescued from a combinatorial phage
display library prepared from an HCMV-infected donor. Fourteen recombinant
Fabs were tested against HCMV-positive PBLs from a patient with ongoing
HCMV infection. Three clones were found to react specifically with the
nuclei of these cells. These three recombinant Fabs were subsequently
tested, individually and pooled together, against 60 PBL samples taken from
immunosuppressed patients. The reactivity observed was comparable to that
obtained with mouse monoclonal antibodies commercially available for this
purpose. The three recombinant Fabs were shown to react specifically with
the 65-kDa viral tegument phosphoprotein encoded by UL83 (pUL83), which is
the most abundant viral antigen in HCMV-infected PBLs.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Use of recombinant human antibody fragments for detection of cytomegalovirus antigenemia
Department of Immunology, Scripps Research Institute, La Jolla, California 92037, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|